NCT04842630 2024-02-09
A Phase 1 Dose Escalation and Expansion Study Of SHR-1916 In Subjects With Locally Advanced Or Metastatic Solid Tumors
Jiangsu HengRui Medicine Co., Ltd.
Phase 1 Terminated
Clinical Trials
22 trialsNCT01642342 2022-08-24
Recombinant Albumin Fusion Protein sEphB4-HSA in Treating Patients With Metastatic or Recurrent Solid Tumors
University of Southern California
Phase 1 Terminated
NCT01573780 2022-08-15
Gemcitabine Hydrochloride and Smac Mimetic TL32711 in Treating Patients With Advanced Solid Tumors
Roswell Park Cancer Institute
Phase 1 Terminated
NCT02070406 2019-02-28
Gene-Modified T Cells, Vaccine Therapy, and Ipilimumab in Treating Patients With Locally Advanced or Metastatic Malignancies
Jonsson Comprehensive Cancer Center
Phase 1 Terminated
NCT01705106 2018-05-30
Capecitabine and Celecoxib in Patients With Solid Cancers That Have Been Previously Treated With Standard Therapies
University of Chicago
Phase 1 Terminated
NCT01324115 2015-03-05
NG-Nitro-L-Arginine in Treating Patients With Advanced Solid Tumors
Cancer Research UK
Phase 1 Terminated
NCT00002948 2014-07-02
High-Dose Topotecan and Peripheral Stem Cell Transplantation in Treating Patients With Refractory Cancer
Yale University
Phase 1 Terminated
NCT00003009 2014-05-22
Inhaled Interleukin-2 in Treating Patients With Metastatic or Unresectable Cancer
University of Southern California
Phase 1 Terminated
NCT00112684 2014-02-24
Alvocidib in Treating Patients With Locally Advanced or Metastatic Solid Tumors
National Cancer Institute (NCI)
Phase 1 Terminated
NCT00436579 2014-02-24
Sorafenib in Treating Patients With Advanced Solid Tumors
National Cancer Institute (NCI)
Phase 1 Terminated
NCT00701298 2014-02-24
Decitabine With or Without Interferon Alfa-2b in Treating Patients With Unresectable or Metastatic Solid Tumors
National Cancer Institute (NCI)
Phase 1 Terminated
NCT00369200 2013-12-11
AFP464 in Treating Patients With Advanced Solid Tumors
National Cancer Institute (NCI)
Phase 1 Terminated
NCT00012194 2013-07-09
7-hydroxystaurosporine and Cisplatin in Treating Patients With Advanced Malignant Solid Tumors
National Cancer Institute (NCI)
Phase 1 Terminated
NCT00009958 2013-05-16
Vaccine Therapy With or Without Sargramostim in Treating Patients With Cancer
National Cancer Institute (NCI)
Phase 1 Terminated
NCT01602627 2013-02-07
Hsp90 Inhibitor AUY922 in Treating Older Patients With Advanced Solid Malignancies
Case Comprehensive Cancer Center
Phase 1 Terminated
NCT00066625 2013-02-01
Oxaliplatin and Bortezomib in Treating Patients With Advanced Cancer
National Cancer Institute (NCI)
Phase 1 Terminated
NCT00010205 2013-01-25
Benzoylphenylurea in Treating Patients With Advanced Cancer
National Cancer Institute (NCI)
Phase 1 Terminated
NCT00030693 2013-01-24
Vaccine Therapy in Treating Patients With Metastatic Solid Tumors
National Cancer Institute (NCI)
Phase 1 Terminated
NCT00049088 2013-01-24
Bortezomib and Docetaxel in Treating Patients With Advanced Solid Tumors
National Cancer Institute (NCI)
Phase 1 Terminated
NCT00086970 2013-01-24
Ifosfamide With or Without O(6)-Benzylguanine in Treating Patients With Unresectable, Metastatic Solid Tumors
National Cancer Institute (NCI)
Phase 1 Terminated
NCT00028561 2013-01-17
BMS-247550 Plus Carboplatin in Treating Patients With Recurrent or Refractory Solid Tumors
National Cancer Institute (NCI)
Phase 1 Terminated
NCT01147029 2012-05-01
GSAO in Treating Patients With Advanced Solid Tumors That Have Not Responded to Therapy
Cancer Research UK
Phase 1 Terminated